We studied diagnostic and treatment values of the blood levels of platelet activation markers PNA, PMA, PLyA, PAC-1, and CD62P in 30 patients with acute ischemic stroke (median NIHSS score 4 (2; 6)) before and after treatment as well as in comparison with the control group. The levels of these markers were measured by flow cytometry. In patients with acute ischemic stroke, the levels of PLyA, PAC-1, and CD62P were significantly increased in comparison with the controls; therapy significantly reduced the levels of PAC-1, CD62P, and PMA in patients with acute ischemic stroke. The areas under the ROC curve differentiating acute ischemic stroke from healthy controls for PAC-1, CD62P, and PLyA were 0.694, 0.862, and 0.760, respectively. Our findings suggest that the levels of PLyA, PAC-1, and CD62P can be potential noninvasive biomarkers of acute ischemic stroke.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bansal S, Sangha KS, Khatri P. Drug treatment of acute ischemic stroke. Am. J. Cardiovasc. Drugs. 2013;13(1):57-69. doi: https://doi.org/10.1007/s40256-013-0007-6
Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke. 2001;32(1):133-138. doi: https://doi.org/10.1161/01.str.32.1.133
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197-223. doi: https://doi.org/10.1016/S0140-6736(12)61689-4
D’Mello C, Almishri W, Liu H, Swain MG. Interactions Between Platelets and Inflammatory Monocytes Affect Sickness Behavior in Mice With Liver Inflammation. Gastroenterology. 2017;153(5):1416-1428.e2. doi: https://doi.org/10.1053/j.gastro.2017.08.011
Fateh-Moghadam S, Htun P, Tomandl B, Sander D, Stellos K, Geisler T, Langer H, Walton K, Handschu R, Garlichs C, Daniel W.G, Gawaz M. Hyperresponsiveness of platelets in ischemic stroke. Thromb. Haemost. 2007;97(6):974-948.
Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, Hacke W; CAPRIE Investigators. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke. 2004;35(5):1147-1152. doi: https://doi.org/10.1161/01.STR.0000124122.71702.64
Kannan M, Ahmad F, Saxena R. Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings. Blood Rev. 2019;37:100583. doi: https://doi.org/10.1016/j.blre.2019.05.007
Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson LM, Truelsen T, O’Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, Risk Factors Study 2010 (GBD 2010); GBD Stroke Experts Group. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob. Health. 2013;1(5):e259-81. doi: https://doi.org/10.1016/S2214-109X(13)70089-5
Latchaw RE, Alberts MJ, Lev MH, Connors JJ, Harbaugh RE, Higashida RT, Hobson R, Kidwell CS, Koroshetz WJ, Mathews V, Villablanca P, Warach S, Walters B; American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, and the Interdisciplinary Council on Peripheral Vascular Disease. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke. 2009;40(11):3646-3678.doi: https://doi.org/10.1161/STROKEAHA.108.192616
Marquardt L, Anders C, Buggle F, Palm F, Hellstern P, Grau AJ. Leukocyte-platelet aggregates in acute and subacute ischemic stroke. Cerebrovasc. Dis. 2009;28(3):276-282. doi: https://doi.org/10.1159/000228710
Pusch G, Debrabant B, Molnar T, Feher G, Papp V, Banati M, Kovacs N, Szapary L, Illes Z. Early Dynamics of Pselectin and Interleukin 6 Predicts Outcomes in Ischemic Stroke. J. Stroke Cerebrovasc. Dis. 2015;24(8):1938-1947. doi: https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.05.005
Santhakumar AB, Bulmer AC, Singh I. A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk. J. Hum. Nutr. Diet. 2014;27(1):1-21. doi: https://doi.org/10.1111/jhn.12177
Singhal R, Chawla S, Rathore DK, Bhasym A, Annarapu GK, Sharma V, Seth T, Guchhait P. Development of pro-inflammatory phenotype in monocytes after engulfing Hb-activated platelets in hemolytic disorders. Clin. Immunol. 2017;175:133-142. doi: https://doi.org/10.1016/j.clim.2016.12.007
Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, Wang L, Jiang Y, Li Y, Wang Y, Chen Z, Wu S, Zhang Y, Wang D, Wang Y, Feigin VL; NESS-China Investigators. Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults. Circulation. 2017;135(8):759-771. doi: https://doi.org/10.1161/CIRCULATIONAHA.116.025250
Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S, Li Y, Wang L, Liu Y, Yin P, Liu J, Yu S, Tan F, Barber RM, Coates MM, Dicker D, Fraser M, González-Medina D, Hamavid H, Hao Y, Hu G, Jiang G, Kan H, Lopez AD, Phillips MR, She J, Vos T, Wan X, Xu G, Yan LL, Yu C, Zhao Y, Zheng Y, Zou X, Naghavi M, Wang Y, Murray CJ, Yang G, Liang X. Causespecific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387:251-272. doi: https://doi.org/10.1016/S0140-6736(15)00551-6
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 172, No. 11, pp. 575-581, November, 2021
Rights and permissions
About this article
Cite this article
Zhang, Y., Ma, Z., Liu, Q. et al. Clinical Significance of PAC-1, CD62P, and Platelet-Leukocyte Aggregates in Acute Ischemic Stroke. Bull Exp Biol Med 172, 543–548 (2022). https://doi.org/10.1007/s10517-022-05429-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-022-05429-y